Dr. Parveen Ahlawat

Professional Journey

Achievements

• Training from top medical college
• Specialization from top institution
• Fellowship in oncology from The Royal Marsden Hospital, London
• Training in CyberKnife from USA
• More than 85 research publications on the treatment of head and neck cancers
• Reviewed multiple research articles in various international journals
• Written many chapters for books on head and neck cancers
• Invited to teach and train other radiation oncologists in head and neck cancer radiotherapy
• Numerous awards and recognitions in his professional career
• Delivered various talks and lectures at international conferences

Research and publications in international journals

• Health-related quality of life assessment for head-and-neck cancer patients during and at 3 months after radiotherapy – A prospective, analytical questionnaire-based study. National Journal of Maxillofacial Surgery. 2019. Parveen Ahlawat et al.
• Prognostic factors, failure patterns and survival analysis in patients with resectable oral squamous cell carcinoma of the tongue. Radiation Oncology Journal. 2019. Parveen Ahlawat et al.
• Re-irradiation with IMRT for recurrent head and neck cancer: A single-institutional report on disease control, survival, and toxicity. Reports of Practical Radiotherapy and Oncology. 2017. Parveen Ahlawat et al.
• Use of definitive locoregional radiotherapy for consolidation in de-novo metastatic head and neck cancer responding to systemic therapy. Indian Journal of Cancer. 2021. Parveen Ahlawat et al.
• Effectiveness of Head-and-Neck Molecular Imaging Reporting and Data System Criterion in Head-and-Neck Squamous Cell Carcinoma PostConcurrent Chemoradiotherapy. Indian J Nucl Med. 2023. Parveen Ahlawat et al.
• Depth of invasion as a predictor of survival in stage III squamous cell carcinoma of the oral tongue. The Laryngoscope. 2021. Parveen Ahlawat et al.
• Tumour volumes: Predictors of early treatment response in locally advanced head and neck cancers treated with definitive chemoradiation. Reports of Practical Radiotherapy and Oncology. 2016. Parveen Ahlawat et al.
• Utilization and incorporation of tumor volume data in staging and prognostication of head and neck squamous cell carcinoma treated with definitive radiotherapy: A systematic review. Asian Journal of Oncology. 2015. Parveen Ahlawat et al.
• Failure patterns of head and neck squamous cell carcinoma treated with radical radiotherapy by intensity modulated radiotherapy technique using focal volume and dosimetric method. Head Neck. 2019. Parveen Ahlawat et al.
• Comparison between chemotherapy (weekly cisplatin) enhanced radiotherapy and biotherapy (cetuximab) enhanced radiotherapy in locally advanced head and neck cancer – first retrospective study in Asian population. Asia-Pacific Journal of Clinical Oncology. 2016. Parveen Ahlawat et al.
• Sinonasal teratocarcinosarcoma treated with surgery followed by volumetric modulated radiotherapy: a case report with review of literature. Radiation Oncology Journal. 2018. Parveen Ahlawat et al.
• Randomized controlled study comparing simultaneous modulated accelerated radiotherapy versus simultaneous integrated boost intensity modulated radiotherapy in the treatment of locally advanced head and neck cancer. Journal of the Egyptian National Cancer Institute. 2018. Parveen Ahlawat et al.
• Dosimetric impact of set up errors in head and neck cancer patients treated by Image guided radiotherapy. Journal of medical physics. 2016. Parveen Ahlawat et al.
• Weekly versus three-weekly cisplatin based concurrent chemoradiotherapy as definitive treatment in head and neck cancer- where do we stand? Gulf Journal of Oncology. 2016. Parveen Ahlawat et al.
• Dosimetric Comparison between Intensity Modulated Radiotherapy and 3-Dimensional Conformal Radiotherapy in the Treatment of Rectal Cancer. Asian Pacific Journal of Cancer Prevention. 2016. Parveen Ahlawat et al.
• Improving the accuracy of target volume delineation by combined use of CT, MRI and PET in head and neck carcinomas. Journal of Cancer Research and Therapeutics. 2015. Parveen Ahlawat et al.
• Radiation-induced dental caries, prevention and treatment – A systematic review. National Journal of Maxillofacial Surgery. 2015. Parveen Ahlawat et al.
• Retrospective analysis of treatment outcomes following reirradiation in locoregionally recurrent head and neck cancer patients: A single institutional study. Asian Pacific Journal of Clinical Oncology. 2015. Parveen Ahlawat et al.
• Dental Pulp Status of Posterior Teeth in Patients with Oral and Oropharyngeal Cancer Treated with Concurrent Chemoradiotherapy. Journal of Endodontics. 2015. Parveen Ahlawat et al.
• Dental pulp status of posterior teeth in patients with Oral and Oropharyngeal cancer treated with radiotherapy – 1 year follow up. Journal of Endodontics. 2018. Parveen Ahlawat et al.
• Cardiac dose reduction with Deep-Inspiratory Breath Hold technique of radiotherapy for left sided breast cancer. Journal of Medical Physics. 2017. Parveen Ahlawat et al..
• Case report “Role of 68Ga-Prostate-Specific Membrane Antigen PET/CT in Disease Assessment in Glioblastoma Within 48 Hours of Surgery.” Clinical Nuclear Medicine. 2020. Parveen Ahlawat et al.
• Prospective study of neoadjuvant chemoradiotherapy using intensity-modulated radiotherapy and 5 fluorouracil for locally advanced rectal cancer – toxicities and response assessment. Cancer Management and Research. 2018. Parveen Ahlawat et al.
• Rising incidence of rectal carcinoma in the young – Is it a concern? An Indian perspective. Cancer Prevention & Current Research. 2017. Parveen Ahlawat et al.
• Male Breast Cancer: An 8-years’ experience in a single tertiary oncology centre in India. International Journal of Medical Pediatrics and Oncology. 2016. Parveen Ahlawat et al.
• Rare presentation of Adenoid cystic carcinoma presenting as retro-orbital mass: a case report. Ophthalmol Case Rep. 2018. Parveen Ahlawat et al.
• Long-term outcomes and toxicity with re-irradiation for recurrent/second primary head and neck cancer. Journal of Carcinogenesis. 2016. Parveen Ahlawat et al.
• IMRT in carcinoma cervix – maximizing the gain and nipping the side effects – RGCI experience. Journal of Carcinogenesis. 2016. Parveen Ahlawat et al.
• Simultaneous Integrated Boost to treat locally advanced squamous cell carcinoma of head and neck – A strike off between acute toxicities and early response? What do we choose? Journal of Carcinogenesis. 2016. Parveen Ahlawat et al.
• Tumour Volume – Strong predictors of early treatment response in locally advanced head and neck cancers treated with definitive chemo radiation. Journal of Carcinogenesis. 2016. Parveen Ahlawat et al.
• The impact of tumour regression in locally advanced carcinoma cervix during external beam radiotherapy and the need for adaptive planning. Journal of Carcinogenesis. 2016. Parveen Ahlawat et al.
• Image guided interstitial brachytherapy for locally advanced disease after external beam radiotherapy in a case of carcinoma cervix – our institutional experience. Journal of Carcinogenesis. 2016. Parveen Ahlawat et al.
• Comparison of the outcomes between locally advanced cervical adenocarcinoma and squamous cell carcinoma patients treated with definitive chemoradiation. Journal of Carcinogenesis. 2016. Parveen Ahlawat et al.
• Correlation of MRI derived parameters and SUV uptake obtained from FDG- PET-CT with human papillomavirus status in oropharyngeal squamous cell carcinomas. Annals of Oncology. 2019. Parveen Ahlawat et al.
• Challenges seen with peri-neural invasion in head and neck cancer – A review article. Oral Oncology Reports 2023. Parveen Ahlawat et al.
• Survival Outcomes in Different Sino-nasal Malignancies: An Institutional Review. The Journal of Current Oncology 2023. Parveen Ahlawat et al.
• Treatment Delay during Radiotherapy of Cancer Patients due to COVID-19 Pandemic. Asian Pac J Cancer Prev. 2022. Parveen Ahlawat et al.
• Myxofibrosarcoma of Head and Neck Region – A Rare Case Report. Indian J Otolaryngol Head Neck Surg. 2023. Parveen Ahlawat et al.
• Role of neoadjuvant therapy in resectable pancreatic carcinoma: a review article – Annals of Pancreatic Cancer 2024. Parveen Ahlawat et al.
• Incorporation of tumour volume data in predicting early outcome in locally advanced head and neck cancer treated with definitive chemoradiation. Parveen Ahlawat et al.
• SMART boost technique to treat locally advanced squamous cell carcinoma of head and neck how smart is it? A feasibility study. Parveen Ahlawat et al.
• Does local control have an impact on outcome in patients treated with re-irradiation in head and neck cancer? An institutional experience. Parveen Ahlawat et al.
• Case report of vaginal melanoma. Journal of Carcinogenesis. 2016. Parveen Ahlawat et al.
• Survival outcomes comparison between simultaneous integrated boost IMRT and sequential IMRT in head and neck cancers. ESTRO Spain 2021. Parveen Ahlawat et al.
• Inter-Correlations Between Various High-Risk Pathological Factors in Resected Buccal Mucosal Squamous Cell Carcinoma. ASTRO Chicago 2021. Parveen Ahlawat et al.
• Tumour volume as prognostic factor for recurrent head and neck cancers treated with re-irradiation. ESTRO Spain 2021. Parveen Ahlawat et al.
• Would full-dose radiotherapy benefit patients with synchronous oligometastatic head and neck squamous cell carcinoma? ASTRO Chicago 2021. Parveen Ahlawat et al.
• Comparison between two-dose levels versus three-dose levels IMRT in head and neck cancers. ESTRO Spain 2021. Parveen Ahlawat et al.
• Impact of anterior commissure involvement in early glottic cancer treated with radical IMRT. ESTRO Spain 2021. Parveen Ahlawat et al.
• Dosimetric impact of tumour regression in carcinoma cervix treated with radical IMRT. ESTRO Spain 2021. Parveen Ahlawat et al.
• Impact of human papilloma virus on treatment outcomes in oropharyngeal cancer in India. ESTRO Spain 2021. Parveen Ahlawat et al.
• Pre-treatment hemoglobin as a surrogate marker for survival in head and neck squamous cell carcinoma. ESTRO Spain 2021. Parveen Ahlawat et al.
• Simultaneous integrated boost IMRT versus sequential IMRT in head and neck cancers. ESTRO Spain 2021. Parveen Ahlawat et al.
• Comparison of therapy outcomes between 2-dimensional radiotherapy and IMRT for early glottic cancer. ESTRO Spain 2021. Parveen Ahlawat et al.
• Wide histological spectrum of sinonasal malignancies and survival outcomes – an institutional review. ESTRO Spain 2021. Parveen Ahlawat et al.
• Use of definitive locoregional radiotherapy for consolidation in de-novo metastatic head and neck cancer responding to systemic therapy. ESTRO Spain 2021. Parveen Ahlawat et al.
• Impact of IGRT on cervical cancer: tumour regression, replanning, and dosimetric changes. ESTRO 2024. Parveen Ahlawat et al.
• Inter-correlations of pathological factors in hard palate cancer: insights from surgical specimens. ESTRO 2024. Parveen Ahlawat et al.
• Prognostic impact of posterior commissure involvement in early glottic cancer. ESTRO 2024. Parveen Ahlawat et al.
• Set-up errors and determination of planning target volume margin for IGRT for head and neck cancers. ESTRO 2024. Parveen Ahlawat et al.
• Lymphovascular invasion as prognostic factor in locally advanced oral tongue cancer. ESTRO 2024. Parveen Ahlawat et al.
• Inter-correlations between pathological prognostic features in resected buccoalveolar complex cancer. ESTRO 2024. Parveen Ahlawat et al.
• Three-dimensional tumour volume predicts early response in recurrent oropharyngeal cancer. ESTRO 2024. Parveen Ahlawat et al.
• Relationship and concordance between CT, MRI and PET for target delineation of oropharyngeal cancer. ESTRO 2024. Parveen Ahlawat et al.
• Progressive decline in dental pulp sensitivity in oropharyngeal cancer treated with radiotherapy. ESTRO 2024. Parveen Ahlawat et al.
• Depth of invasion predicting survival with adjuvant radiotherapy in early tongue squamous carcinoma. ESTRO 2024. Parveen Ahlawat et al.
• Search for the ideal palliative fractionation regimen in HNC – A single institutional experience. ESTRO 2024. Parveen Ahlawat et al.
• Dosimetric comparison between HALCYON and CLINAC iX for locally advanced head and neck cancer. ESTRO 2024. Parveen Ahlawat et al.
• Comparison of disease outcomes between younger and older patients with carcinoma oral tongue. ESTRO 2024. Parveen Ahlawat et al.
• Post-Adjuvant Radiation failure pattern in bucco-alveolar complex by focal volume. ESTRO 2024. Parveen Ahlawat et al.
• Depth of Invasion as an Independent Predictor of Survival in Patients of Stage III Squamous Cell Carcinoma of the Oral Tongue. ESTRO 2024. Parveen Ahlawat et al.
• Impact of Radiation Treatment Delay Due to COVID-19 Pandemic. IJROBP 2022. Parveen Ahlawat et al.
• Role of Functional Imaging in evaluation of Radiation Colitis. ASTRO 2020. Parveen Ahlawat et al.
• Definitive radiotherapy in oligometastatic head and neck cancers responding to systemic therapy. Radiotherapy and Oncology. 2019. Parveen Ahlawat et al.
• Initial experience in Hip Prosthesis using Photon Beam for RT treatment. Parveen Ahlawat et al.
• Effectiveness of HAN-MI-RADS (head and neck molecular imaging-reporting and data system) criterion in head and neck squamous cell carcinoma post concurrent chemoradiotherapy. Parveen Ahlawat et al.
• Role of induction chemotherapy combined with radical chemoradiotherapy in unresectable oral cancer. Parveen Ahlawat et al.
• DE_HyART trial: Study protocol for phase 2 randomised controlled study assessing the role of dose escalation using [18F] FMISO PET CT in head and neck cancers. Parveen Ahlawat et al.
• Institution-specific setup error analysis and PTV margin determination for pharyngeal cancer. ESTRO 2025, Vienna, Austria. Parveen Ahlawat et al.
• Unraveling prognostic inter-correlations in gingival squamous cell carcinoma: implications for risk stratification. ESTRO 2025, Vienna, Austria. Parveen Ahlawat et al.
• Radiotherapy-induced pulpal changes in teeth adjacent to mandibulectomy defects: a longitudinal study. ESTRO 2025, Vienna, Austria. Parveen Ahlawat et al.
• Recovery and determinants of health-related quality of life in non-HPV mediated oropharyngeal cancer following chemoradiation. ESTRO 2025, Vienna, Austria. Parveen Ahlawat et al.
• Laryngeal preservation in locally advanced laryngeal and hypopharyngeal cancers: a retrospective study from an Indian cancer center. ESTRO 2025, Vienna, Austria. Parveen Ahlawat et al.
• Re-Irradiation outcomes in recurrent HPV non-mediated oropharyngeal cancer: the predictive role of tumor volume. ESTRO 2025, Vienna, Austria. Parveen Ahlawat et al.
• Tracking quality of life: A study of patients with locally advanced laryngeal cancer undergoing radical IMRT. ESTRO 2025, Vienna, Austria. Parveen Ahlawat et al.
• Evaluating concordance between CT, PET, and MRI for target volume delineation in locally advanced laryngeal cancer. ESTRO 2025, Vienna, Austria. Parveen Ahlawat et al.
• Exploring the link between nerve involvement and poor prognosis in oral tongue cancer. ESTRO 2025, Vienna, Austria. Parveen Ahlawat et al.